Novo Nordisk A/S
NYSE: NVO
$107.63
+$2.27 (+2.2%)
Closing Price on November 7, 2024
NVO Articles
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday morning include Chesapeake Energy, JPMorgan, Melco Crown Entertainment, Navistar, Randgold Resources, Silver Wheaton, Verifone.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday morning include Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva Pharmaceutical and Verifone.
Published:
Last Updated:
At this point, bad news is coming in consistently to the point that any significant piece of good news could catapult Sanofi stock higher, making it an interesting choice for dip-buyers.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday morning include BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto and Twenty-First Century Fox.
Published:
Last Updated:
Janus Capital has now launched the Obesity ETF, which has a strategy of investing in companies that provide treatment and care for obesity and obesity‐related disease.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday, February 8 include Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK and Tableau Software.
Published:
Last Updated:
Tuesday's top analyst upgrades, downgrades and initiations include AMD, Apple, Dollar General, Noble Energy and Oracle.
Published:
Thursday's top analyst upgrades, downgrades and initiations include Alcatel-Lucent, Apple, Coach, Etsy, Intel, MannKind, Netflix, SanDisk and Starbucks.
Published:
We ran a screen searching for Bank of America Merrill Lynch Buy-rated Japanese and European-listed American depositary shares that have at least 20% of sales in North America.
Published:
ThinkstockInvestors have become increasingly anxious about how badly the U.S. equity and fixed income markets will be battered as the American government marches toward a potential default. Of...
Published:
Jon OggInvestors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What they often miss out on are the instances where analysts downgrade these stocks, particularly...
Published:
Last Updated:
These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Monday, June 17, 2013. They include Teradata, T-Mobile US, Lululemon and Time Warner Cable.
Published:
Last Updated:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, May 28, 2013. They include Eli Lilly, W.R. Grace, Intelsat and GlaxoSmithKline.
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Thursday. Activision Blizzard Inc. (NASDAQ: ATVI) raised to Overweight at Piper...
Published:
Last Updated: